Development Level

Tbio 2 | 10,625
Tchem 1 | 1,890
Tclin 1 | 602

IMPC Phenotype

abnormal kidney morphology 1 | 30
abnormal lymph node morphology 1 | 3
decreased circulating serum al... 1 | 79
increased circulating HDL chol... 1 | 63
increased circulating alanine ... 1 | 11
increased circulating aspartat... 1 | 17
increased circulating choleste... 1 | 53
increased circulating triglyce... 1 | 24
increased lactate dehydrogenas... 1 | 3

Disease

Obesity 3 | 616
Cholestasis 2 | 93
Crohn Disease 2 | 97
Drug-Induced Liver Injury 2 | 118
Fatty liver disease 2 | 86
Leber congenital amaurosis 2 | 72
Liver disease 2 | 219
Metabolic syndrome X 2 | 155
Primary cholangitis 2 | 2
Sclerosing cholangitis 2 | 17
atypical teratoid / rhabdoid tumor 2 | 4,369
glioblastoma 2 | 5,572
medulloblastoma, large-cell 2 | 6,234
osteosarcoma 2 | 7,933
ovarian cancer 2 | 8,491
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
primitive neuroectodermal tumor 2 | 3,031
psoriasis 2 | 6,685
Anemia 1 | 252
Calculus in biliary tract 1 | 2
Cancer 1 | 2,346
Cholelithiasis Prevention 1 | 1
Cholestasis of pregnancy 1 | 5
Connective tissue disease 1 | 59
Constipation 1 | 43
Distal arthrogryposis 1 | 45
Extravasation of Diagnostic and Therapeutic Materials 1 | 6
Fragile X syndrome 1 | 31
Gangliocytoma 1 | 1
Hepatomegaly 1 | 10
Intestinal Neoplasms 1 | 11
Intrahepatic cholestasis 1 | 19
Lethargy 1 | 4
Liver carcinoma 1 | 217
Liver diseases 1 | 66
Liver neoplasms 1 | 108
Lupus Erythematosus, Systemic 1 | 73
Lymphopenia 1 | 35
Multiple myeloma 1 | 1,327
Necrosis 1 | 51
Neurodegenerative disease 1 | 383
Primary biliary cirrhosis 1 | 45
Progressive intrahepatic cholestasis 1 | 4
Rheumatoid Arthritis 1 | 1,170
Supratentorial primitive neuroectodermal tumor 1 | 7
Systemic scleroderma 1 | 66
Vici syndrome 1 | 16
Weight Gain 1 | 87
Weight decreased 1 | 18
active Crohn's disease 1 | 918
adult high grade glioma 1 | 2,148
aldosterone-producing adenoma 1 | 664
diabetes mellitus 1 | 1,663
fibroadenoma 1 | 557
gastric cancer 1 | 436
interstitial cystitis 1 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
lung cancer 1 | 4,473
malignant mesothelioma 1 | 3,163
medulloblastoma 1 | 1,524
nephrosclerosis 1 | 329
spina bifida 1 | 1,064
systemic lupus erythematosus 1 | 172
tuberculosis 1 | 1,563
urothelial carcinoma 1 | 318

Tissue

Blood and immune system 4 | 17,994
Cardiovascular System 4 | 17,957
Digestive Tract 4 | 18,472
Endocrine System 4 | 18,511
Female tissues 4 | 18,646
Liver and Pancreas 4 | 18,135
Male tissues 4 | 17,968
Nervous System 4 | 18,560
Respiratory system 4 | 17,483
Skin and soft tissues 4 | 18,114
Urinary Tract 4 | 18,443

Target Family

Enzyme 1 | 4,146
GPCR 1 | 408
Non-IDG 1 | 11,969
Nuclear Receptor 1 | 48

Grant Application

5R01DK091327-05 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Myosin phosphatase Rho-interacting protein MPRIP Tbio Enzyme -1.05601 13.2 144
Autophagy protein 5 ATG5 Tbio Non-IDG -2.81350 559.7 557
G-protein coupled bile acid receptor 1 GPBAR1 Tchem GPCR -2.48255 315.6 177
Bile acid receptor NR1H4 Tclin Nuclear Receptor -2.52741 306.4 272